The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of PSA progression after initiation of enzalutamide or abiraterone: Real-world data on metastatic castration-resistant prostate cancer (mCRPC).
 
Fernando López-Campos
Consulting or Advisory Role - Astellas Pharma; Janssen Oncology; MSD
Speakers' Bureau - Astellas Pharma; Janssen
Research Funding - Astellas Pharma
Travel, Accommodations, Expenses - Astellas Pharma; Janssen
 
David Lorente
No Relationships to Disclose
 
Casilda Llacer Perez
No Relationships to Disclose
 
Miguel Ramirez-Backhaus
No Relationships to Disclose
 
Paula Peleteiro
No Relationships to Disclose
 
Alfonso Gomez-Iturriaga
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen
Speakers' Bureau - Astellas Pharma; Janssen
 
Ivan Henriquez-López
No Relationships to Disclose
 
Rebeca Lozano
Honoraria - Bayer; Janssen; Roche; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; Janssen; MSD; Roche; Sanofi
 
Nuria Romero
No Relationships to Disclose
 
Teresa Alonso-Gordoa
No Relationships to Disclose
 
Javier Molina-Cerrillo
No Relationships to Disclose
 
Joaquin Navarro-Castellón
No Relationships to Disclose
 
Ana Castaño
No Relationships to Disclose
 
Lira Pelari
No Relationships to Disclose
 
Antonio Hernández-Corrales
No Relationships to Disclose
 
Virginia Morillo
No Relationships to Disclose
 
Raquel García
No Relationships to Disclose
 
Carlos Ferrer Albiach
No Relationships to Disclose
 
Elena Castro
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Clovis Oncology; Janssen-Cilag; Pfizer; Roche
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck; MSD Oncology; Pfizer
Research Funding - AstraZeneca (Inst); Bayer (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Janssen; Roche
 
David Olmos
Honoraria - Astellas Pharma (Inst); Bayer; Janssen
Consulting or Advisory Role - AstraZeneca (Inst); Bayer; Bayer (Inst); Clovis Oncology; Daiichi Sankyo; Janssen; Janssen (Inst); MSD Oncology
Research Funding - Astellas Medivation (Inst); AstraZeneca (Inst); Bayer (Inst); Genentech/Roche (Inst); Janssen (Inst); MSD Oncology (Inst); Pfizer (Inst); Tokai Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca Spain; Bayer; Ipsen; Janssen; Roche